General MedicationsORALGeneric
E-Z-CAT DRY
BARIUM SULFATE
Standard Dose
40%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview E-Z-CAT DRY is listed in Drugs@FDA under application 208036 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient BARIUM SULFATE Form and strength FOR SUSPENSION;ORAL - 40% Sponsor BRACCO Submission history Latest submission status date: 2019-04-30 00:00:00.
Structured Monograph
Clinical summary
Approval overview E-Z-CAT DRY is listed in Drugs@FDA under application 208036 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient BARIUM SULFATE Form and strength FOR SUSPENSION;ORAL - 40% Sponsor BRACCO Submission history Latest submission status date: 2019-04-30 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.